Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Molecular determinants of lxr alpha agonism

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Wang, M. M.
  • Thomas, J.
  • Burris, Thomas
  • Schkeryantz, J.
  • Michael, L. F.

publication date

  • November 2003

journal

  • Journal of Molecular Graphics & Modelling  Journal

abstract

  • Liver X receptors (LXRs) are nuclear receptors that participate in the regulation of cholesterol, bile acid, and glucose metabolism. Despite the identification of the natural oxysterol and nonsteroidal ligands for LXRalpha, little is known about the structure of the LXRalpha ligand-binding domain (LBD). We constructed a three-dimensional (3D) homology model of the LBD of LXRalpha based on the crystal structure of the retinoic acid receptor gamma (RARgamma) and all-trans retinoic acid complex. We combined molecular modeling and classical structure-function techniques to define the interactions between the LBD and three structurally diverse ligands, 22(R)-hydroxycholesterol (22RHC), N-(2,2,2-trifluoro-ethyl)-N-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]-benzenesulfonamide (T0901317) and (3-[3-[(2-chloro-3-trifluoromethyl-benzyl)-(2,2-diphenyl-ethyl)-amino]-propoxy]-phenyl)-acetic acid (GW3965). Sixteen individual amino acid point mutations were made in the predicted ligand-binding cavity of the LBD, and each of these mutant receptors was assessed for their ability to be activated by these three ligands. The majority of individual mutations resulted in lack of activation by all three ligands. Two residues were identified that resulted in a significant increase in basal activity while retaining responsiveness to the ligands. Interestingly, a number of residues were identified that appear to be selective in their response to a particular ligand, indicating that these three ligands recognize distinct structural components within the ligand-binding cavity. These data, together with our docking study, enable us to identify the amino acids that coordinate the interaction of both steroidal and non-steroidal ligands in the ligand-binding pocket of LXRalpha.

subject areas

  • Amino Acid Sequence
  • Binding Sites
  • Cell Line
  • DNA-Binding Proteins
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Sequence Data
  • Molecular Structure
  • Orphan Nuclear Receptors
  • Point Mutation
  • Protein Conformation
  • Receptors, Cytoplasmic and Nuclear
  • Transcription, Genetic
scroll to property group menus

Research

keywords

  • atherosclerosis
  • ligand-binding domain
  • liver X receptors
  • single-point mutation
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1093-3263

Digital Object Identifier (DOI)

  • 10.1016/s1093-3263(03)00159-1

PubMed ID

  • 12932788
scroll to property group menus

Additional Document Info

start page

  • 173

end page

  • 181

volume

  • 22

issue

  • 2

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support